Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: Pancho Villa who wrote (1037)	2/13/1998 11:37:00 PM
From: Trey Yon	Read Replies (1) \| Respond to of 1359

Pancho more of your usual BS, with the exeception of your obtuse reference to Barron's (2/9) "Bucking the Trend" Paul Duggan interview. BTW from the look of the article this guy mostly follows Banks. .... What does he know about Biotech? They don't mention his Pans. So Barron's readers will never understand his line of reasoning. As for more factual stuff, there was a large jump in short interest last month. So maybe there is more room on the downside. I guess we'll see. But I think it's safe to say that most of the EASY money was made from $22 down over the last 6 months. Are there any Geniuses on the thread who went SHORT back in '96 in the $30's or $40's ??? As for arguements about the Balance Sheet WHO CARES? THE STREET CERTAINTLY DIDN'T GIVE A FLIP TODAY ... IPIC Budged down 1/8th point. WHETHER ITS BEATING STREET ESTIMATES OR HAVING A CRAPPIE Balance Sheet. Come on WAKE UP, THIS IS BIOTECH what really matters IS: A) IPIC is in the DOGHOUSE UNTIL the LEGAL Picture clears up OR GETS WORSE. and B) How drug development in the pipeline is progressing. Frankly, I FEEL more comfortable now with 3 mill SHORT as a floor of support & future demand . BTW, I bought more this AM. As for ITRC being a $2 stock, I think Art Samberg & others would take issue with that statement. It's enough to know that it came public at $16, has run to $30 AND has NEVER CLOSED BELOW $15 So go ahead SHORT A BUNCH of ITRC as WELL. When you & I learn to Manage our position, & get out of the business of trying to PREDICT future price movements. We'll both be better investors . BTW, if memory serves me the FDA averaged around 9 months to review an NDA in 1997